Amyloid particles facilitate surface-catalyzed cross-seeding by acting as promiscuous nanoparticles.

Saccharomyces cerevisiae Sup35 yeast prion protein amyloid β peptide atomic force microscopy protein aggregation and assembly

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
07 09 2021
Historique:
entrez: 31 8 2021
pubmed: 1 9 2021
medline: 8 1 2022
Statut: ppublish

Résumé

Amyloid seeds are nanometer-sized protein particles that accelerate amyloid assembly as well as propagate and transmit the amyloid protein conformation associated with a wide range of protein misfolding diseases. However, seeded amyloid growth through templated elongation at fibril ends cannot explain the full range of molecular behaviors observed during cross-seeded formation of amyloid by heterologous seeds. Here, we demonstrate that amyloid seeds can accelerate amyloid formation via a surface catalysis mechanism without propagating the specific amyloid conformation associated with the seeds. This type of seeding mechanism is demonstrated through quantitative characterization of the cross-seeded assembly reactions involving two nonhomologous and unrelated proteins: the human Aβ42 peptide and the yeast prion-forming protein Sup35NM. Our results demonstrate experimental approaches to differentiate seeding by templated elongation from nontemplated amyloid seeding and rationalize the molecular mechanism of the cross-seeding phenomenon as a manifestation of the aberrant surface activities presented by amyloid seeds as nanoparticles.

Identifiants

pubmed: 34462352
pii: 2104148118
doi: 10.1073/pnas.2104148118
pmc: PMC8433567
pii:
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0
Prion Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/T020415/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J008001/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S003312/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M02427X/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Nanoscale. 2018 Dec 7;10(45):20894-20913
pubmed: 30225490
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9758-63
pubmed: 23703910
Front Mol Neurosci. 2018 Feb 22;11:53
pubmed: 29520218
Genetics. 1996 Dec;144(4):1375-86
pubmed: 8978027
Nat Rev Neurol. 2010 Oct;6(10):551-9
pubmed: 20842183
Mol Cell Biol. 1999 Dec;19(12):8103-12
pubmed: 10567536
Genetics. 1981 Aug;98(4):691-711
pubmed: 7037537
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7160-4
pubmed: 1831267
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8691-6
pubmed: 17485668
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
pubmed: 17267609
Nat Protoc. 2016 Feb;11(2):252-72
pubmed: 26741409
Biophys J. 2013 Dec 17;105(12):2811-9
pubmed: 24359753
ACS Chem Neurosci. 2010 Jan 20;1(1):13-8
pubmed: 22778803
J Biol Chem. 2003 Dec 5;278(49):49636-43
pubmed: 14507919
FEBS J. 2009 Mar;276(5):1266-81
pubmed: 19175671
Nat Chem Biol. 2020 Jul;16(7):756-765
pubmed: 32284601
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20455-60
pubmed: 23184970
Chem Biol. 2014 Feb 20;21(2):295-305
pubmed: 24485763
J Biol Chem. 2020 May 22;295(21):7470-7480
pubmed: 32291284
PLoS Pathog. 2013 Sep;9(9):e1003537
pubmed: 24068917
Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10165-70
pubmed: 16006506
Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8):
pubmed: 30745294
J Neurochem. 2012 Sep;122(5):883-90
pubmed: 22734715
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8926-31
pubmed: 18579777
Nature. 2006 Aug 3;442(7102):585-9
pubmed: 16810177
Angew Chem Int Ed Engl. 2018 Jul 9;57(28):8370-8382
pubmed: 29446868
Science. 2017 Oct 6;358(6359):116-119
pubmed: 28882996
J Mol Biol. 1997 Oct 31;273(3):729-39
pubmed: 9356260
FEBS Open Bio. 2021 Apr;11(4):999-1013
pubmed: 33548114
Lancet Neurol. 2006 Jan;5(1):64-74
pubmed: 16361024
Nature. 2005 Jun 9;435(7043):765-72
pubmed: 15944694
PLoS Biol. 2004 Oct;2(10):e321
pubmed: 15383837
PLoS Biol. 2007 Feb;5(2):e24
pubmed: 17253904
Nat Rev Mol Cell Biol. 2007 Jul;8(7):552-61
pubmed: 17585315
J Biol Chem. 2004 Apr 23;279(17):17490-9
pubmed: 14752113
iScience. 2020 Aug 29;23(9):101512
pubmed: 32920487
Biochim Biophys Acta Proteins Proteom. 2019 Nov;1867(11):140257
pubmed: 31352057
J Intern Med. 2018 Mar;283(3):218-237
pubmed: 29360284
J Mol Biol. 2018 Dec 7;430(24):5304-5312
pubmed: 30267747
ACS Chem Neurosci. 2020 Mar 18;11(6):909-918
pubmed: 32069013
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):
pubmed: 33431654
Chem Biol. 2014 Feb 20;21(2):172-3
pubmed: 24560165
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7671-6
pubmed: 24817693
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
J Am Chem Soc. 2018 Feb 21;140(7):2493-2503
pubmed: 29357227
Nat Commun. 2019 Oct 29;10(1):4760
pubmed: 31664019
Prion. 2013 Sep-Oct;7(5):359-68
pubmed: 24025483
Elife. 2017 Sep 07;6:
pubmed: 28880146
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6098-102
pubmed: 15829582
Cell. 2012 Mar 16;148(6):1188-203
pubmed: 22424229
EMBO J. 2001 Nov 15;20(22):6236-45
pubmed: 11707395
Genet Res. 1981 Apr;37(2):173-82
pubmed: 7021322
Methods Enzymol. 1999;309:256-74
pubmed: 10507029
Nature. 2017 Jan 12;541(7636):217-221
pubmed: 28052060
Genetics. 2010 Feb;184(2):393-400
pubmed: 19917766
Science. 1995 May 12;268(5212):880-4
pubmed: 7754373
Science. 2000 Aug 25;289(5483):1317-21
pubmed: 10958771
Biophys Rev. 2017 Aug;9(4):329-338
pubmed: 28812278
Biophys J. 2015 Nov 17;109(10):1999-2000
pubmed: 26588558

Auteurs

Nadejda Koloteva-Levine (N)

Kent Fungal Group, School of Biosciences, University of Kent, CT2 7NJ Canterbury, United Kingdom.

Liam D Aubrey (LD)

Kent Fungal Group, School of Biosciences, University of Kent, CT2 7NJ Canterbury, United Kingdom.

Ricardo Marchante (R)

Kent Fungal Group, School of Biosciences, University of Kent, CT2 7NJ Canterbury, United Kingdom.

Tracey J Purton (TJ)

Kent Fungal Group, School of Biosciences, University of Kent, CT2 7NJ Canterbury, United Kingdom.

Jennifer R Hiscock (JR)

School of Physical Sciences, University of Kent, CT2 7NJ Canterbury, United Kingdom.

Mick F Tuite (MF)

Kent Fungal Group, School of Biosciences, University of Kent, CT2 7NJ Canterbury, United Kingdom.

Wei-Feng Xue (WF)

Kent Fungal Group, School of Biosciences, University of Kent, CT2 7NJ Canterbury, United Kingdom; w.f.xue@kent.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH